beta-Adrenoceptor inverse agonists in asthma.
Beta(2)-adrenoceptor (beta(2)-AR) agonists are very effective bronchodilators and play a major role in every stage of asthma management. However, their chronic, regular use is associated with detrimental effects including an increase in asthma-related deaths. Conversely, recent data suggest that certain beta-blockers, specifically beta-adrenoceptor (beta-AR) inverse agonists, may be useful in the chronic treatment of asthma. Here we review the data for this observation and the signaling pathways that may be involved. The data suggest that beta(2)-AR signaling is required to produce maximal airway inflammation and hyperresponsiveness, and the signaling pathway responsible for these effects is likely the non-canonical beta-arrestin-2 pathway. Therefore, beta-AR inverse agonists may produce their beneficial chronic effects by inhibiting constitutive or ligand-induced activation of this pathway. Both lung parenchymal and hematopoietic cells appear to be involved in mediating the beneficial effects of beta-AR inverse agonists.
Dickey
Burton F
BF
Department of Pulmonary Medicine, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Walker
Julia K L
JK
Hanania
Nicola A
NA
Bond
Richard A
RA
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000188:drug therapy / Q000503:physiopathology; D054314:Drug Inverse Agonism; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D015398:Signal Transduction / Q000187:drug effects
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents
Am J Cardiol. 2000 Jun 15;85(12):1467-71
10856394
Pulm Pharmacol Ther. 2008;21(1):115-24
17689122
J Clin Invest. 2006 Jan;116(1):163-73
16374521
J Card Fail. 2003 Aug;9(4):266-77
13680547
J Clin Invest. 2003 Aug;112(4):566-74
12925697
Br J Pharmacol. 2000 Jul;130(5):1131-9
10882399
Pharmacol Ther. 2007 Sep;115(3):360-74
17681610
Am J Cardiol. 2009 Feb 1;103(3):295-300
19166678
Nature. 1995 Mar 16;374(6519):272-6
7885448
Mol Pharmacol. 2004 Jan;65(1):196-206
14722251
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62
17925438
Ann Intern Med. 2006 Jun 20;144(12):904-12
16754916
Am J Respir Cell Mol Biol. 2008 Mar;38(3):256-62
18096872
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7321-5
2552439
FASEB J. 2008 Jul;22(7):2134-41
18337459
Annu Rev Immunol. 2008;26:205-32
18304002
Annu Rev Physiol. 2009;71:509-35
18851708
Circulation. 1996 Dec 1;94(11):2807-16
8941106
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4948-53
15069206
Eur Respir J. 2006 Jun;27(6):1286-306
16772391
Lancet. 1990 Jul 7;336(8706):1-6
1694945
Pulm Pharmacol Ther. 2008;21(1):134-41
17703976
Mol Pharmacol. 1994 Mar;45(3):490-9
7908406
Br Heart J. 1975 Oct;37(10):1022-36
1191416
Ann Intern Med. 2002 Nov 5;137(9):715-25
12416945
Am J Respir Cell Mol Biol. 2010 Sep;43(3):269-75
19805483
Naunyn Schmiedebergs Arch Pharmacol. 1997 Jun;355(6):689-98
9205952
Annu Rev Physiol. 2007;69:535-60
17002593
N Engl J Med. 1996 May 23;334(21):1349-55
8614419
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2435-40
19171883
Br J Pharmacol. 1999 Jul;127(5):1099-104
10455254
J Clin Invest. 2003 Aug;112(4):619-26
12925702
J Biol Chem. 2004 Aug 20;279(34):35518-25
15205453
Biochim Biophys Acta. 2004 May 3;1691(2-3):169-79
15110997
Am J Respir Crit Care Med. 2008 Oct 1;178(7):695-700
18565952
Am J Respir Cell Mol Biol. 2009 Apr;40(4):388-97
18931328
Curr Opin Pulm Med. 2003 Nov;9(6):504-8
14534403
Trends Pharmacol Sci. 2001 Jun;22(6):273-6
11395153
J Cardiovasc Pharmacol. 1989;14 Suppl 5:S38-43
2478808
Prim Care Respir J. 2005 Oct;14(5):236-41
16701736
Annu Rev Physiol. 2007;69:401-22
16945069
J Biol Chem. 1993 Mar 5;268(7):4625-36
8095262
Mol Med. 2008 Mar-Apr;14(3-4):195-204
18079995
Chest. 2006 Jan;129(1):15-26
16424409
Mol Pharmacol. 1990 Jan;37(1):44-9
1967818
Am J Cardiol. 2008 Oct 1;102(7):871-4
18805113
Annu Rev Physiol. 2007;69:483-510
17305471
J Allergy Clin Immunol. 2007 Jan;119(1):235-44
17208607